To stay healthy, our cells rely on a self-cleaning mechanism that removes defective or unnecessary components. This process, ...

Journal Editorial Report: Trump ditches the mileage mandates at the center of Biden’s EV push. Photo: Chip Somodevilla/Getty Images/Mike Blake/Reuters Not long ago, auto makers were touting electric ...

Researchers at Stanford found a way to cure or prevent Type 1 diabetes in mice using a combined blood stem cell and islet cell transplant. The procedure creates a hybrid immune system that stops ...

The professor will no longer be able to teach a class on diversity after she showed students a diagram that included the “Make America Great Again” slogan as an example of white supremacy. By ...

Jennie Richardson is a TV Features and Lists Writer for Collider, and a graduate student pursuing an MFA in Fiction Writing. In other words, she really loves stories. Coming off of last week's ...

Beyond nominating video games for different categories of awards, The Game Awards has also propagated a Future Class in the past. Those recognized as a part of the Future Class cohort were meant to ...

We're into Week 9 of the 2025 NFL season and there are four teams on bye with the Eagles, Bucs, Browns and Jets off. Below we'll help you out with those tough fantasy football lineup decisions with ...

Week 9 of the NFL season approaches. It's shaping up to be a good one, as a pretty entertaining season continued on that pace in Week 8. In one of the bigger surprises of the season the Patriots ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

This is a published version of our weekly Forbes Crypto Confidential newsletter. Sign up here to get it days earlier free in your inbox. Crypto’s October 10 flash crash saw an estimated $19 billion in ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.

Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...